Yazar "Tumkaya, L." için listeleme
-
Is adalimumab protective in ischemia?reperfusion injury in lung?
Kurt, A.; Tumkaya, L.; Kalkan, Y.; Turut, H.; Cure, M.C.; Cure, E.; Usta, M. (Mashhad University of Medical Sciences, 2015)Objective(s): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I?R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor?alpha (TNF??) inhibitor agent. We aimed ... -
Topiramate Reduces Aortic Cross-Clamping-Induced Lung Injury in Male Rats
Kurt, A.; Kalkan, Y.; Turut, H.; Cure, M.C.; Tumkaya, L.; Cure, E. (NLM (Medline), 2018)BACKGROUND: Topiramate (TPM) decreases cytokine release and generation of reactive oxygen species (ROS). Cytokine and endothelin-1 (ET-1) secretion and ROS formation play an important role in ischemia-reperfusion (I/R) ... -
Zoledronic acid aggravates kidney damage during ischemia reperfusion injury in rat
Sehitoglu, I.; Tumkaya, L.; Bedir, R.; Kalkan, Y.; Cure, M.C.; Yucel, A.F.; Cure, E. (Begell House Inc., 2015)Introduction: Zoledronic acid (ZA), a bisphosphonate, increases the levels of cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-?), and reactive oxygen species (ROS) in subjects without cancer. ...